April 2, 2020 10:28 AM EDT

Sue Desmond-Hellmann joins Pfizer board; Kite Pharma taps ally in push to expand CAR-T

ENDPOINTS

→ Sue Desmond-Hellmann will be joining Pfizer’s board of directors, four months after stepping down as CEO of the Bill and Melinda Gates Foundation …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sue Desmond-Hellmann joins Pfizer board; Kite Pharma taps ally in push to expand CAR-T

ENDPOINTS

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Sue Desmond-Hell­mann joins Pfiz­er board; Kite Phar­ma taps al­ly in push to ex­pand CAR-T

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Sue Desmond-Hellmann joins Pfizer board; Kite Pharma taps ally in push to expand CAR-T